OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study
Alhumaidi B. Alabbas
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 9, pp. 101745-101745
Open Access | Times Cited: 4
Alhumaidi B. Alabbas
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 9, pp. 101745-101745
Open Access | Times Cited: 4
Showing 4 citing articles:
Identification of cholinesterases inhibitors from flavonoids derivatives for possible treatment of Alzheimer's disease: In silico and in vitro approaches
Morteza Sadeghi, Seyedehmasoumeh Seyedebrahimi, Mustafa Ghanadian, et al.
Current Research in Structural Biology (2024) Vol. 7, pp. 100146-100146
Open Access | Times Cited: 3
Morteza Sadeghi, Seyedehmasoumeh Seyedebrahimi, Mustafa Ghanadian, et al.
Current Research in Structural Biology (2024) Vol. 7, pp. 100146-100146
Open Access | Times Cited: 3
A Multifaceted Computational Approach to Understanding the MERS-CoV Main Protease and Brown Algae Compounds’ Interaction
Hattan S. Gattan, Maha Alawi, Leena H. Bajrai, et al.
Marine Drugs (2023) Vol. 21, Iss. 12, pp. 626-626
Open Access | Times Cited: 4
Hattan S. Gattan, Maha Alawi, Leena H. Bajrai, et al.
Marine Drugs (2023) Vol. 21, Iss. 12, pp. 626-626
Open Access | Times Cited: 4
Supplementary Methods from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
(2024)
Open Access
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
(2024)
Open Access
Supplementary Methods from Activating Point Mutations in the <i>MET</i> Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
(2024)
Open Access
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
(2024)
Open Access
